Loading
Redsense Medical AB (publ) Stock: price and insider trades · Sweden
2 insiders bought €9,587 of shares over the last 90 days, the latest by Susanne Olausson, filed 11 Sept 2026.
Redsense Medical AB (publ): what insiders have been doing
Redsense Medical AB (publ) is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. 2 insiders have disclosed 2 filings since 21 October 2025.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €9,587. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €6,105, bought by Susanne Olausson and made public on 11 September 2026 (0.12% of market cap). On the buying side, the filings list 1 board member and 1 chief executive among the declarants.
Compared with its exchange (881 companies, median 8 filings), a count of 2 filings is below the norm. Since 2016, the database holds 36 purchases and 4 sales by insiders of the company.
The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 11 September 2026, 40 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Vivos Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
44
Thresholds
n/a
Buy Volume
€2M
36 ops. · all time
Sell Volume
€319,496
4 ops. · all time
Who traded when
BuySaleSusanne Olausson3 buys
Sebastien Bollue1 buy
Fundamental score
Ranked 22,474 of 26,280 companies
26.2
score / 100
Value14
Quality39
FCF yld-14%
Earn yld-13%
EV/EBITDA·
ROE-1.8%
Gross mgn65%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 3.43
Analyst consensus
Income statement
RevenueSEK 24M
Gross profitSEK 15.6M65% margin
EBITDA-SEK 6.5M-27% margin
Net income-SEK 7.2M-2.5% margin
Valuation
P/Book1.6x
Beta0.45
Balance sheet & cash
Market capSEK 56.4M
Free Cash Flow-SEK 8M
Profitability & ownership
ROE-1.8%
ROA-1.3%
% insiders42.9%
% institutions14.1%
Last declaration on 11 September 2026
Declarations44 total
25,000 shares@ SEK 2.750.12% mcap11.7% of flowAktieISIN SE0006965158FI:csv-7c94a1c38566d58efdaa
Canonical exit: 9 Dec 2026 (T+90)
15,075 shares@ SEK 2.590.068% mcap100.0% of flowAktieISIN SE0006965158FI:csv-0247bfacf0d881c9c4be
Canonical exit: 8 Dec 2026 (T+90)
10,000 shares@ SEK 4.950.077% mcap21.9% of flowAktieISIN SE0006965158FI:A003S338-1
Canonical exit: 15 Dec 2025 (T+90)
20,000 shares@ SEK 5.580.17% mcap48.6% of flowAktieISIN SE0006965158FI:A003Q597-1
Canonical exit: 8 Oct 2025 (T+90)
7,000 shares@ SEK 7.7038.8% of flowAktieISIN SE0006965158FI:csv-d5409065516769a08017
Canonical exit: 1 Jan 2025 (T+90)
6,000 shares@ SEK 7.5332.6% of flowAktieISIN SE0006965158FI:csv-05e6e77c16c227696010
Canonical exit: 31 Dec 2024 (T+90)
10,000 shares@ SEK 6.645911.2% of flowAktieISIN SE0006965158FI:csv-db622b820338c283be34
Canonical exit: 23 Dec 2024 (T+90)
1,700 shares@ SEK 7.1626.1% of flowAktieISIN SE0006965158FI:csv-67242eb39ecde8418e19
Canonical exit: 9 Feb 2023 (T+90)
3,300 shares@ SEK 10.3573.9% of flowAktieISIN SE0006965158FI:csv-4386af8a1a72312503cc
Canonical exit: 7 Dec 2022 (T+90)
3,000 shares@ SEK 20.8011.6% of flowAktieISIN SE0006965158FI:csv-cf1ef712facfb2401af8
Canonical exit: 9 Mar 2022 (T+90)
1,818,419 shares@ €4.6475AktieISIN SE0006965158FI:csv-33236c8a58bc0d4ac6f3
99,485 shares@ SEK 48.5014.3% of flowAktieISIN SE0009695158FI:csv-ef02c6958f4252f5dd95
318,419 shares@ SEK 48.5045.8% of flowAktieISIN SE0009695158FI:csv-fa83847e96c299e46fbb
Canonical exit: 7 Jan 2021 (T+90)
109,150 shares@ SEK 25.689.7% of flowAktieISIN SE0006965158FI:csv-6f7f9fab758aee7f6cee
300,000 shares@ SEK 10.0010.1% of flowAktieISIN SE0006965158FI:csv-81b4035f981a3ca3a809
3,000 shares@ SEK 10.7016.9% of flowAktieISIN SE0006965158FI:csv-3f10fc3d01a59745310a
Canonical exit: 24 Nov 2019 (T+90)
2,000 shares@ SEK 10.7017.4% of flowAktieISIN SE0006965158FI:csv-191fe6772c0e74a189f9
Canonical exit: 24 Nov 2019 (T+90)
72,463 shares@ SEK 1.3823.4% of flowOptionFI:csv-2f7ea7dc7cc518b54704
Canonical exit: 22 Sept 2019 (T+90)
72,463 shares@ SEK 1.380.3% of flowOptionFI:csv-7a6019b6a6fa667613b2
Canonical exit: 22 Sept 2019 (T+90)
72,463 shares@ SEK 1.3882.6% of flowTeckningsoptionISIN SE0006965158FI:csv-ca5db7553d5830c4071d
Canonical exit: 22 Sept 2019 (T+90)
72,463 shares@ SEK 1.3853.5% of flowTeckningsoptionISIN SE0006965158FI:csv-7cff304e053800f78b47
Canonical exit: 22 Sept 2019 (T+90)
72,463 shares@ SEK 1.3836.4% of flowTeckningsoptionISIN SE0006965158FI:csv-5c6c034b0331b01ea8e9
2,300 shares@ SEK 11.3013.9% of flowAktieISIN SE0006965158FI:csv-604af3df35a3937b9084
Canonical exit: 29 Aug 2019 (T+90)
25 of 44 declarations
About Redsense Medical AB (publ)
Redsense Medical AB (publ) is a Swedish company focused on developing medical solutions for patient monitoring. It is listed on the XSTO market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
